Your browser is no longer supported. Please, upgrade your browser.
TFX Teleflex Incorporated monthly Stock Chart
TFX [NYSE]
Teleflex Incorporated
IndexS&P 500 P/E36.39 EPS (ttm)10.16 Insider Own0.30% Shs Outstand46.44M Perf Week-4.05%
Market Cap17.71B Forward P/E27.76 EPS next Y13.31 Insider Trans-4.28% Shs Float46.25M Perf Month2.58%
Income479.30M PEG3.05 EPS next Q2.31 Inst Own94.00% Short Float1.45% Perf Quarter7.66%
Sales2.53B P/S7.01 EPS this Y133.70% Inst Trans0.45% Short Ratio2.85 Perf Half Y-3.10%
Book/sh66.69 P/B5.54 EPS next Y30.42% ROA7.40% Target Price410.45 Perf Year3.29%
Cash/sh11.55 P/C32.00 EPS next 5Y11.95% ROE16.00% 52W Range221.27 - 405.07 Perf YTD-1.82%
Dividend1.36 P/FCF66.97 EPS past 5Y19.10% ROI11.10% 52W High-8.76% Beta1.01
Dividend %0.37% Quick Ratio2.30 Sales past 5Y7.10% Gross Margin54.80% 52W Low67.02% ATR10.88
Employees14400 Current Ratio3.40 Sales Q/Q-13.10% Oper. Margin17.10% RSI (14)46.13 Volatility2.86% 2.81%
OptionableYes Debt/Eq0.78 EPS Q/Q-86.30% Profit Margin19.00% Rel Volume0.57 Prev Close374.25
ShortableYes LT Debt/Eq0.75 EarningsJul 30 BMO Payout13.10% Avg Volume234.85K Price369.57
Recom1.80 SMA20-1.86% SMA500.25% SMA2005.24% Volume134,728 Change-1.25%
Jan-31-20Reiterated Needham Buy $408 → $423
Aug-02-19Reiterated Needham Buy $325 → $403
Jun-11-19Initiated Wells Fargo Outperform $345
Apr-24-19Downgrade Needham Strong Buy → Buy $325
Feb-22-19Reiterated Needham Strong Buy $300 → $325
Oct-16-18Initiated Barclays Equal Weight $266
Sep-10-18Upgrade Needham Buy → Strong Buy $279 → $300
Aug-03-18Reiterated Needham Buy $298 → $279
May-14-18Reiterated Needham Buy $293 → $298
May-04-18Reiterated Needham Buy $285 → $293
Apr-04-18Initiated Goldman Neutral $257
Nov-10-17Resumed Piper Jaffray Overweight $295
Nov-03-17Reiterated Needham Buy $237 → $285
Sep-08-17Upgrade Leerink Partners Mkt Perform → Outperform
Sep-06-17Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-06-17Reiterated Needham Buy $228 → $237
Mar-07-17Initiated Needham Buy $221
Jan-06-17Upgrade Jefferies Hold → Buy
Jul-12-16Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Jun-14-16Reiterated Barclays Overweight $170 → $183
Jul-31-20 12:41PM  
Jul-30-20 06:00PM  
08:15AM  
06:45AM  
06:30AM  
06:00AM  
Jul-28-20 03:18PM  
Jul-23-20 12:33PM  
Jul-21-20 06:30AM  
Jul-20-20 06:30AM  
Jul-14-20 06:30AM  
Jul-09-20 06:05PM  
Jun-23-20 06:30AM  
Jun-22-20 06:30AM  
Jun-17-20 11:20AM  
Jun-08-20 05:00PM  
Jun-05-20 12:17PM  
Jun-04-20 10:07AM  
Jun-03-20 06:45AM  
Jun-02-20 06:30AM  
May-30-20 11:31AM  
May-27-20 10:10AM  
May-21-20 05:00PM  
10:49AM  
08:49AM  
May-20-20 02:35PM  
May-18-20 06:30AM  
May-04-20 10:55AM  
06:45AM  
06:30AM  
Apr-30-20 06:30PM  
07:55AM  
06:30AM  
Apr-29-20 05:15PM  
05:00PM  
11:09AM  
06:45AM  
Apr-23-20 12:32PM  
Apr-20-20 05:00PM  
11:22AM  
Apr-17-20 06:45AM  
Apr-15-20 11:40AM  
Apr-02-20 09:23AM  
Mar-30-20 12:18PM  
Mar-21-20 11:30AM  
Mar-19-20 12:27AM  
Mar-16-20 10:51AM  
Mar-11-20 06:45AM  
Mar-03-20 08:13PM  
Feb-25-20 06:45AM  
Feb-24-20 09:03AM  
09:01AM  
Feb-20-20 08:05AM  
06:45AM  
06:30AM  
Feb-17-20 02:09PM  
10:04AM  
Feb-14-20 05:00PM  
Feb-13-20 05:00PM  
12:31PM  
Feb-06-20 06:45AM  
Jan-28-20 11:18AM  
Jan-22-20 06:30AM  
Jan-16-20 02:03PM  
Jan-14-20 06:30AM  
Jan-13-20 10:46AM  
Jan-10-20 08:38AM  
Jan-08-20 09:00AM  
Jan-07-20 06:30AM  
Jan-03-20 10:57AM  
Jan-02-20 09:40AM  
06:45AM  
Dec-30-19 06:45AM  
Dec-19-19 06:45AM  
Dec-06-19 02:30PM  
Nov-21-19 06:45AM  
Nov-11-19 06:45AM  
05:07AM  
Nov-04-19 06:45AM  
05:06AM  
Nov-01-19 07:19AM  
Oct-31-19 07:55AM  
06:45AM  
06:30AM  
Oct-30-19 12:44PM  
Oct-25-19 01:16PM  
Oct-24-19 10:32AM  
Oct-17-19 06:45AM  
Oct-11-19 11:13AM  
Oct-10-19 01:21PM  
Oct-09-19 07:50AM  
Oct-07-19 06:52AM  
06:30AM  
Sep-25-19 06:45AM  
Sep-17-19 01:25PM  
Sep-16-19 06:45AM  
Sep-13-19 07:48PM  
06:45AM  
Sep-06-19 09:15PM  
Sep-04-19 05:23AM  
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products consist of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management for patients in the hospital and individuals in the home care markets. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was founded in 1943 and is headquartered in Wayne, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Klasko Stephen K. M.D.DirectorJul 27Option Exercise58.2520011,6501,321Jul 28 09:05 PM
Klasko Stephen K. M.D.DirectorJul 27Sale386.3520077,2701,121Jul 28 09:05 PM
Klasko Stephen K. M.D.DirectorJun 25Option Exercise58.2520011,6501,321Jun 26 04:41 PM
Klasko Stephen K. M.D.DirectorMay 26Option Exercise58.2520011,6501,321May 27 04:35 PM
Klasko Stephen K. M.D.DirectorMay 26Sale375.1420075,0281,121May 27 04:35 PM
Hicks Cameron PCorp. VP, HR & CommunicationsMay 11Option Exercise92.4190783,8178,157May 11 05:20 PM
Hicks Cameron PCorp. VP, HR & CommunicationsMay 07Option Exercise85.541,400119,7568,650May 11 05:20 PM
Hicks Cameron PCorp. VP, HR & CommunicationsMay 07Sale343.571,400480,9987,250May 11 05:20 PM
Deren JohnVP & Chief Accounting OfficerMay 05Sale330.101,093360,797986May 07 05:17 PM
Klasko Stephen K. M.D.DirectorApr 27Option Exercise58.2520011,650938Apr 28 05:07 PM
Klasko Stephen K. M.D.DirectorApr 27Sale342.2620068,452738Apr 28 05:07 PM
Klasko Stephen K. M.D.DirectorMar 25Option Exercise58.2520011,650938Mar 26 12:54 PM
Klasko Stephen K. M.D.DirectorMar 25Sale254.7520050,950738Mar 26 12:54 PM
Deren JohnVP & Chief Accounting OfficerFeb 28Option Exercise218.932,184478,1384,263Mar 03 04:15 PM
Deren JohnVP & Chief Accounting OfficerFeb 28Sale346.172,184756,0352,079Mar 03 04:15 PM
Leyden James JVP, General Counsel, SecretaryFeb 27Option Exercise61.343,200196,28817,341Feb 27 07:49 PM
Leyden James JVP, General Counsel, SecretaryFeb 27Sale344.28750258,20715,886Feb 27 07:49 PM
Klasko Stephen K. M.D.DirectorFeb 25Option Exercise58.2520011,650938Feb 26 01:36 PM
Klasko Stephen K. M.D.DirectorFeb 25Sale360.9520072,190738Feb 26 01:36 PM
Klasko Stephen K. M.D.DirectorJan 27Option Exercise58.2520011,650936Jan 28 02:56 PM
Klasko Stephen K. M.D.DirectorJan 27Sale375.7120075,142736Jan 28 02:56 PM
Klasko Stephen K. M.D.DirectorDec 26Option Exercise61.3420012,268936Dec 26 05:43 PM
Klasko Stephen K. M.D.DirectorDec 26Sale374.3520074,870736Dec 26 05:43 PM
Hicks Cameron PVice President, Global HRNov 29Option Exercise85.541,00085,5407,106Dec 02 04:09 PM
POWELL THOMAS EExecutive Vice President & CFONov 26Option Exercise121.005,000605,00015,697Nov 26 06:13 PM
Hicks Cameron PVice President, Global HRNov 26Option Exercise85.541,300111,2027,406Nov 27 05:53 PM
POWELL THOMAS EExecutive Vice President & CFONov 26Sale348.705,0001,743,51010,697Nov 26 06:13 PM
Hicks Cameron PVice President, Global HRNov 26Sale350.001,300455,0006,106Nov 27 05:53 PM
Klasko Stephen K. M.D.DirectorNov 25Option Exercise61.3420012,268936Nov 26 05:35 PM
Klasko Stephen K. M.D.DirectorNov 25Sale346.6320069,326736Nov 26 05:35 PM
POWELL THOMAS EExecutive Vice President & CFONov 12Option Exercise121.007,500907,50018,197Nov 12 07:05 PM
POWELL THOMAS EExecutive Vice President & CFONov 12Sale330.667,5002,479,94610,697Nov 12 07:05 PM
SMITH BENSONDirectorNov 04Option Exercise59.758,481506,74057,290Nov 06 05:00 PM
SMITH BENSONDirectorNov 04Sale345.378,4812,929,12048,809Nov 06 05:00 PM
SMITH BENSONDirectorOct 31Option Exercise59.7517,0001,015,75065,809Nov 01 05:19 PM
SMITH BENSONDirectorOct 31Sale340.0117,0005,780,11748,809Nov 01 05:19 PM
POWELL THOMAS EExecutive Vice President & CFOOct 29Option Exercise121.007,500907,50018,197Oct 31 06:31 PM
POWELL THOMAS EExecutive Vice President & CFOOct 29Sale327.427,5002,455,61910,697Oct 31 06:31 PM
Klasko Stephen K. M.D.DirectorOct 25Option Exercise61.3420012,268936Oct 25 07:20 PM
Klasko Stephen K. M.D.DirectorOct 25Sale316.0120063,201736Oct 25 07:20 PM
POWELL THOMAS EExecutive Vice President & CFOOct 15Option Exercise102.867,500771,48118,197Oct 16 06:37 PM
POWELL THOMAS EExecutive Vice President & CFOOct 15Sale328.447,5002,463,31710,697Oct 16 06:37 PM
POWELL THOMAS EExecutive Vice President & CFOOct 01Option Exercise101.127,500758,40018,197Oct 02 05:31 PM
POWELL THOMAS EExecutive Vice President & CFOOct 01Sale338.117,5002,535,80010,697Oct 02 05:31 PM
Klasko Stephen K. M.D.DirectorSep 25Option Exercise61.3420012,268936Sep 25 06:35 PM
Klasko Stephen K. M.D.DirectorSep 25Sale342.5020068,500736Sep 25 06:35 PM
SMITH BENSONDirectorSep 23Option Exercise59.758,500507,87557,309Sep 25 06:23 PM
SMITH BENSONDirectorSep 23Sale340.008,5002,890,00048,809Sep 25 06:23 PM
POWELL THOMAS EExecutive Vice President & CFOSep 17Option Exercise101.127,500758,40018,197Sep 19 05:46 PM
POWELL THOMAS EExecutive Vice President & CFOSep 17Sale332.907,5002,496,76710,697Sep 19 05:46 PM
POWELL THOMAS EExecutive Vice President & CFOSep 06Option Exercise101.127,500758,40018,197Sep 06 07:28 PM
POWELL THOMAS EExecutive Vice President & CFOSep 06Sale355.527,5002,666,42710,697Sep 06 07:28 PM
Klasko Stephen K. M.D.DirectorAug 26Option Exercise61.3420012,268936Aug 27 04:45 PM
Klasko Stephen K. M.D.DirectorAug 26Sale361.0620072,212736Aug 27 04:45 PM
Hicks Cameron PVice President, Global HRAug 15Option Exercise85.541,00085,5407,376Aug 16 05:00 PM
Hicks Cameron PVice President, Global HRAug 15Sale370.001,000370,0006,376Aug 16 05:00 PM
Deren JohnVP & Chief Accounting OfficerAug 14Option Exercise230.301,601368,7154,015Aug 14 09:57 PM
Deren JohnVP & Chief Accounting OfficerAug 14Sale365.062,004731,5902,011Aug 14 09:57 PM